Mettler-Toledo International, Inc. CapEx decreased by 58.0% to $17.41M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.9%, from $17.26M to $17.41M. Over 4 years (FY 2021 to FY 2025), CapEx shows relatively stable performance with a -0.1% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.76M | $22.43M | $37.78M | $19.15M | $43.24M | $26.82M | $32.03M | $23.20M | $28.75M | $20.96M | $32.42M | $17.39M | $23.81M | $21.42M | $41.28M | $17.26M | $23.88M | $24.49M | $41.50M | $17.41M |
| QoQ Change | — | -1.4% | +68.4% | -49.3% | +125.8% | -38.0% | +19.4% | -27.6% | +23.9% | -27.1% | +54.7% | -46.4% | +36.9% | -10.0% | +92.7% | -58.2% | +38.4% | +2.6% | +69.5% | -58.0% |
| YoY Change | — | — | — | — | +90.0% | +19.6% | -15.2% | +21.1% | -33.5% | -21.9% | +1.2% | -25.0% | -17.2% | +2.2% | +27.3% | -0.8% | +0.3% | +14.3% | +0.6% | +0.9% |
| Segment | FY'21 | FY'24 |
|---|---|---|
| U.S. Operations Segment | $34.97M | $16.54M |
| Chinese Operations Segment | $15.70M | $14.36M |
| Other Operations Segment | $5.65M | $11.68M |
| Swiss Operations Segment | $7.86M | $9.50M |
| Western European Operations Segment | $11.01M | $6.34M |
| Total | $107.58M | $103.90M |
All segment values are derived from annual filings.